11月4日，Hims & Hers Health Inc.盘中上涨6.16%，报27.77美元/股，成交额1.33亿美元。
市场最新关注点转向公司即将披露的季度业绩，一致预期当季营收8.93亿美元，同比增53.88%，每股收益0.06美元，机构近六个月观点整体偏多。
尽管FTC有关误导销售与订阅收费的诉讼、以及减重业务信用卡纠纷问题仍压制风险偏好，但公司此前已请求法院驳回投诉；叠加澳大利亚平台扩张等增长动作，短线情绪有所修复。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.